Ralf Martz Sulague

Dr. Ralf Martz Sulague

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 July 2024 in World Journal of Surgery
Verified
Journal Article
Closed access
PDF file
RSRalf Martz Sulague
Ralf Martz Sulague
FBFrancis Joshua Beloy
Francis Joshua Beloy
JMJillian Reeze Medina
Jillian Reeze Medina
EMEdward Daniel Mortalla
Edward Daniel Mortalla
TCThea Danielle Cartojano
Thea Danielle Cartojano
JKJacques Kpodonu
Jacques Kpodonu

16 November 2022 in Progress in Cardiovascular Diseases
Verified
Journal Article
Closed access
RSRalf Martz Sulague
Ralf Martz Sulague
NSNina Nicole M. Suan
Nina Nicole M. Suan
MMMichael F. Mendoza
Michael F. Mendoza
CLCarl J Lavie
Carl J Lavie

20 September 2024 in Journal of Global Health
Verified
Journal Article
Open access
RSRalf Martz Sulague
Ralf Martz Sulague
PAPia Gabrielle I Alfonso
Pia Gabrielle I Alfonso
JSJaeny Delos Santos
Jaeny Delos Santos
RRRomina Isabel B Ricardo
Romina Isabel B Ricardo
KWKarina Veronica Wilamarta
Karina Veronica Wilamarta
Cardiovascular disease (CVD) was the leading cause of death in Southeast Asia in 2021, causing 1.7 million deaths, or approximately 31% of total deaths in the region [1]. Over the period of 1990 to 2021, there was an upward trend in both the number of crude CVD mortality rates in Southeast Asia (247 deaths/100 000 population) […]

29 December 2022 in Journal of Global Health
Verified
Journal Article
Open access
RSRalf Martz Sulague
Ralf Martz Sulague
XLXuxin Lim
Xuxin Lim
RBRonnie E Baticulon
Ronnie E Baticulon
JKJacques Kpodonu
Jacques Kpodonu
WHY SOUTHEAST ASIA MUST INVEST IN SURGICAL SYSTEMS In past decades, global health and development efforts in Southeast Asia (SEA) have focused on prevailing infectious diseases such as tuberculosis, malaria, and HIV/AIDS, as well as maternal and child care. While these efforts are laudable, there has been a failure to adequately address surgical diseases, which […]

26 March 2025 in Catheterization and Cardiovascular Interventions
Verified
Journal Article
Closed access
JSJaeny Delos Santos
Jaeny Delos Santos
FBFrancis Joshua Beloy
Francis Joshua Beloy
RSRalf Martz Sulague
Ralf Martz Sulague
HOHenry Okudzeto
Henry Okudzeto
JMJillian Reeze Medina
Jillian Reeze Medina
JKJacques Kpodonu
Jacques Kpodonu

19 October 2023 in medRxiv
Verified
Preprint
Open access
PDF file
RSRalf Martz Sulague
Ralf Martz Sulague
FBFrancis Joshua Beloy
Francis Joshua Beloy
JMJillian Reeze Medina
Jillian Reeze Medina
EMEdward Daniel Mortalla
Edward Daniel Mortalla
TCThea Danielle Cartojano
Thea Danielle Cartojano
JKJacques Kpodonu
Jacques Kpodonu
BACKGROUND Artificial intelligence has emerged as a tool to potentially increase efficiency and efficacy of healthcare and improve clinical outcomes. The growing body of knowledge of artificial intelligence applications in cardiac surgery necessitates evaluation of past studies to gain insights to the future direction of artificial intelligence applications in cardiac surgery. This study aims to provide a systematic review of the applications of artificial intelligence in cardiac surgery. METHODS A systematic literature search on artificial intelligence applications in cardiac surgery from 2000 to 2022 was conducted in the following databases: PubMed, Embase, Europe PMC, Epistemonikos, CINAHL, Cochrane Central, Google Scholar, Web of Science, Scopus, Cambridge Core, clinicaltrials.gov, and science. Studies on the implementation of artificial intelligence applications in cardiac surgery and the provision of decision support by the application through simulating clinical decision-making processes of healthcare providers were included. Studies not in English, published only as abstracts, review papers, meta-analyses, clinical trials that were still in progress, and published study protocols were excluded. This study was registered on Prospero (CRD42022377530). RESULTS A total of 42 studies were found that reported on artificial intelligence applications in cardiac surgery, all of which are cohort studies. Nine (21.43%) of the studies measured different parameters regarding cardiac surgeries in general. Meanwhile, 6 (14.29%) studies focused on Heart Transplantation (HT), 4 (9.52%) on Transcatheter Aortic Valve Replacement (TAVR), 3 (7.14%) anchored on Aortic Stenosis, and another 3 (7.14%) on Perioperative Complications. Three topics had 2 (4.76%) studies dedicated to them, namely Coronary Artery Bypass Graft (CABG), Postoperative Atrial Fibrillation (POAF), and Acute Kidney Injury (AKI). The remaining eleven studies have their own unique disease topics, procedures or surgeries in focus (n=11, 1 (2.38%), namely Postoperative Major Bleeding, Early Coronary Revascularization, Heart Valve Surgery, Isolated Mitral Valve Replacement (IMVR), Surgical Aortic Valve Replacement (SAVR), Open-Chest Surgery, Infective endocarditis, Post-Operative Deterioration, Red Blood Cell Transfusion, AKI - related Hippocampal Damage, and Open-Heart Surgery. Regarding evaluation outcomes, 26 studies examined the performance, 32 studies examined clinician outcomes, and 2 studies examined patient outcomes. Of the 42 studies, only 13 were conducted in Lower- and Middle-Income Countries. CONCLUSION Artificial intelligence was used to predict mortality, postoperative length of stay, and complications following cardiac surgeries. It can also improve clinicians’ medical decisions by providing better preoperative risk assessment, stratification, and prognostication. While the application of artificial intelligence in cardiac surgery has greatly progressed in the last two decades, more highly powered studies need to be done to assess challenges and to ensure accuracy and safety for use in clinical practice.